4//SEC Filing
Voermann Karsten 4
Accession 0001809519-25-000008
CIK 0001809519other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:43 PM ET
Size
8.3 KB
Accession
0001809519-25-000008
Insider Transaction Report
Form 4
Voermann Karsten
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-01-08+89,292→ 392,596 total - Exercise/Conversion
Restricted Stock Unit
2025-01-08−89,292→ 267,876 total→ Class A Common Stock (89,292 underlying) - Tax Payment
Class A Common Stock
2025-01-08$4.41/sh−29,035$128,044→ 363,561 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822140
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 6:43 PM ET
- Size
- 8.3 KB